Hunter Perkins Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Hunter Perkins Capital Management, LLC
- $432 Million
- Q4 2025
A detailed history of Hunter Perkins Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 10,887 shares of REGN stock, worth $7.55 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
10,887
Previous 11,616
6.28%
Holding current value
$7.55 Million
Previous $6.53 Million
28.66%
% of portfolio
1.94%
Previous 1.45%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,528Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.6M-
Vanguard Group Inc Valley Forge, PA9.08MShares$6.29 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...